Singapore starts medical marijuana research

PETALING JAYA: Singapore will embark on developing synthetic medicinal cannabinoids as part of its new Synthetic Cannabinoid Biology Programme.
The programme is part of a S$25 million (RM74 million) research initiative called the Synthetic Biology Research and Development Programme, which will be conducted over a period of five years.
It hopes to unlock the therapeutic potential of cannabinoids - chemical compounds found in the cannabis plant - with none of the negative side effects and social ills, according to a report in the Straits Times of Singapore.
Singapore has some of the strictest drug laws in the world.